Rubin H. Flocks and Colloidal Gold Treatments for Prostate Cancer

In the early 1950s, Rubin H. Flocks of the University of Iowa began to treat prostate cancer patients with colloidal gold (Au 198 ) therapy, evolving his technique over nearly 25 years in 1515 patients. We reviewed the long-term outcomes of Flocks' prostate cancer patients as compared to those...

Full description

Saved in:
Bibliographic Details
Published in:TheScientificWorld 2011-01, Vol.11, p.1560-1567
Main Authors: Rosevear, Henry M, Lightfoot, Andrew J, O'Donnell, Michael A, Platz, Charles E, Loening, Stefan A, Hawtrey, Charles E
Format: Article
Language:English
Subjects:
Care and treatment
Colloids
Gold
Health aspects
Prostate cancer
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c461t-cd553ef17029fd0060e5bc0398b1b25a95cb23e05e46c020e5401cff8d324edf3
cites
container_end_page 1567
container_issue
container_start_page 1560
container_title TheScientificWorld
container_volume 11
creator Rosevear, Henry M
Lightfoot, Andrew J
O'Donnell, Michael A
Platz, Charles E
Loening, Stefan A
Hawtrey, Charles E
description In the early 1950s, Rubin H. Flocks of the University of Iowa began to treat prostate cancer patients with colloidal gold (Au 198 ) therapy, evolving his technique over nearly 25 years in 1515 patients. We reviewed the long-term outcomes of Flocks' prostate cancer patients as compared to those patients treated by other methods at the University of Iowa before Flocks' chairmanship. We reviewed archived patient records, Flocks' published data, and long-term survival data from the Iowa Tumor Registry to determine short- and long-term outcomes of Flocks' work with colloidal gold. We also reviewed the literature of Flocks' time to compare his outcomes against those of his contemporaries. The use of colloidal gold, either as primary or adjunctive therapy, provided short- and long-term survival benefit for the majority of Flocks' patients as compared to historical treatment options ( p < 0.001). Flocks' use of colloidal gold for the treatment of locally advanced prostate cancer offered short- and long-term survival benefits compared to other contemporary treatments.
doi_str_mv 10.1100/tsw.2011.145
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_d2ee6003c9294befaf40a8d19fce6297</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A290112645</galeid><doaj_id>oai_doaj_org_article_d2ee6003c9294befaf40a8d19fce6297</doaj_id><sourcerecordid>A290112645</sourcerecordid><originalsourceid>FETCH-LOGICAL-c461t-cd553ef17029fd0060e5bc0398b1b25a95cb23e05e46c020e5401cff8d324edf3</originalsourceid><addsrcrecordid>eNptkdtq3DAQhkVIyfmuDyDIbdYZnez1TWBZmgMEWkoKvROyNNoosa0geVP69tVmQ8lCpAuJmX8-aeYn5CuDijGAyyn_qTgwVjGp9sgRU6KZNVL-3v9wPyTHOT8BiHnD1AE55GVJaOCILH6uuzDS24pe99E-Z2pGR5ex72Nwpqc3sXf0IaGZBhynTH1M9EeKeTIT0qUZLaZT8sWbPuPZ-3lCfl1_e1jezu6_39wtF_czK2s2zaxTSqBnDfDWO4AaUHUWRDvvWMeVaZXtuEBQKGsLvGQlMOv93Aku0XlxQu62XBfNk35JYTDpr44m6LdATCtt0hRsj9pxxLp0a1veyg698RLM3LHWW6x52xTW1Zb1su4GdLb0lky_A93NjOFRr-KrFmXSNd8AzreAlSnvhdHHIrNDyFYveFvc4LVURVV9oirb4RBsHNGHEt8puNgW2DLjnND__xIDvXFbF7f1xm1d3Bb_AKhxmpA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Rubin H. Flocks and Colloidal Gold Treatments for Prostate Cancer</title><source>PubMed (Medline)</source><source>Wiley Online Library Open Access</source><creator>Rosevear, Henry M ; Lightfoot, Andrew J ; O'Donnell, Michael A ; Platz, Charles E ; Loening, Stefan A ; Hawtrey, Charles E</creator><creatorcontrib>Rosevear, Henry M ; Lightfoot, Andrew J ; O'Donnell, Michael A ; Platz, Charles E ; Loening, Stefan A ; Hawtrey, Charles E</creatorcontrib><description>In the early 1950s, Rubin H. Flocks of the University of Iowa began to treat prostate cancer patients with colloidal gold (Au 198 ) therapy, evolving his technique over nearly 25 years in 1515 patients. We reviewed the long-term outcomes of Flocks' prostate cancer patients as compared to those patients treated by other methods at the University of Iowa before Flocks' chairmanship. We reviewed archived patient records, Flocks' published data, and long-term survival data from the Iowa Tumor Registry to determine short- and long-term outcomes of Flocks' work with colloidal gold. We also reviewed the literature of Flocks' time to compare his outcomes against those of his contemporaries. The use of colloidal gold, either as primary or adjunctive therapy, provided short- and long-term survival benefit for the majority of Flocks' patients as compared to historical treatment options ( p &lt; 0.001). Flocks' use of colloidal gold for the treatment of locally advanced prostate cancer offered short- and long-term survival benefits compared to other contemporary treatments.</description><identifier>ISSN: 1537-744X</identifier><identifier>ISSN: 2356-6140</identifier><identifier>EISSN: 1537-744X</identifier><identifier>DOI: 10.1100/tsw.2011.145</identifier><identifier>PMID: 22224070</identifier><language>eng</language><publisher>John Wiley &amp; Sons, Inc</publisher><subject>Care and treatment ; Colloids ; Gold ; Health aspects ; Prostate cancer</subject><ispartof>TheScientificWorld, 2011-01, Vol.11, p.1560-1567</ispartof><rights>COPYRIGHT 2011 John Wiley &amp; Sons, Inc.</rights><rights>2011 Copyright © 2011 Henry M. Rosevear et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c461t-cd553ef17029fd0060e5bc0398b1b25a95cb23e05e46c020e5401cff8d324edf3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201627/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201627/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Rosevear, Henry M</creatorcontrib><creatorcontrib>Lightfoot, Andrew J</creatorcontrib><creatorcontrib>O'Donnell, Michael A</creatorcontrib><creatorcontrib>Platz, Charles E</creatorcontrib><creatorcontrib>Loening, Stefan A</creatorcontrib><creatorcontrib>Hawtrey, Charles E</creatorcontrib><title>Rubin H. Flocks and Colloidal Gold Treatments for Prostate Cancer</title><title>TheScientificWorld</title><description>In the early 1950s, Rubin H. Flocks of the University of Iowa began to treat prostate cancer patients with colloidal gold (Au 198 ) therapy, evolving his technique over nearly 25 years in 1515 patients. We reviewed the long-term outcomes of Flocks' prostate cancer patients as compared to those patients treated by other methods at the University of Iowa before Flocks' chairmanship. We reviewed archived patient records, Flocks' published data, and long-term survival data from the Iowa Tumor Registry to determine short- and long-term outcomes of Flocks' work with colloidal gold. We also reviewed the literature of Flocks' time to compare his outcomes against those of his contemporaries. The use of colloidal gold, either as primary or adjunctive therapy, provided short- and long-term survival benefit for the majority of Flocks' patients as compared to historical treatment options ( p &lt; 0.001). Flocks' use of colloidal gold for the treatment of locally advanced prostate cancer offered short- and long-term survival benefits compared to other contemporary treatments.</description><subject>Care and treatment</subject><subject>Colloids</subject><subject>Gold</subject><subject>Health aspects</subject><subject>Prostate cancer</subject><issn>1537-744X</issn><issn>2356-6140</issn><issn>1537-744X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptkdtq3DAQhkVIyfmuDyDIbdYZnez1TWBZmgMEWkoKvROyNNoosa0geVP69tVmQ8lCpAuJmX8-aeYn5CuDijGAyyn_qTgwVjGp9sgRU6KZNVL-3v9wPyTHOT8BiHnD1AE55GVJaOCILH6uuzDS24pe99E-Z2pGR5ex72Nwpqc3sXf0IaGZBhynTH1M9EeKeTIT0qUZLaZT8sWbPuPZ-3lCfl1_e1jezu6_39wtF_czK2s2zaxTSqBnDfDWO4AaUHUWRDvvWMeVaZXtuEBQKGsLvGQlMOv93Aku0XlxQu62XBfNk35JYTDpr44m6LdATCtt0hRsj9pxxLp0a1veyg698RLM3LHWW6x52xTW1Zb1su4GdLb0lky_A93NjOFRr-KrFmXSNd8AzreAlSnvhdHHIrNDyFYveFvc4LVURVV9oirb4RBsHNGHEt8puNgW2DLjnND__xIDvXFbF7f1xm1d3Bb_AKhxmpA</recordid><startdate>20110101</startdate><enddate>20110101</enddate><creator>Rosevear, Henry M</creator><creator>Lightfoot, Andrew J</creator><creator>O'Donnell, Michael A</creator><creator>Platz, Charles E</creator><creator>Loening, Stefan A</creator><creator>Hawtrey, Charles E</creator><general>John Wiley &amp; Sons, Inc</general><general>TheScientificWorldJOURNAL</general><general>Hindawi Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20110101</creationdate><title>Rubin H. Flocks and Colloidal Gold Treatments for Prostate Cancer</title><author>Rosevear, Henry M ; Lightfoot, Andrew J ; O'Donnell, Michael A ; Platz, Charles E ; Loening, Stefan A ; Hawtrey, Charles E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c461t-cd553ef17029fd0060e5bc0398b1b25a95cb23e05e46c020e5401cff8d324edf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Care and treatment</topic><topic>Colloids</topic><topic>Gold</topic><topic>Health aspects</topic><topic>Prostate cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rosevear, Henry M</creatorcontrib><creatorcontrib>Lightfoot, Andrew J</creatorcontrib><creatorcontrib>O'Donnell, Michael A</creatorcontrib><creatorcontrib>Platz, Charles E</creatorcontrib><creatorcontrib>Loening, Stefan A</creatorcontrib><creatorcontrib>Hawtrey, Charles E</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>TheScientificWorld</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rosevear, Henry M</au><au>Lightfoot, Andrew J</au><au>O'Donnell, Michael A</au><au>Platz, Charles E</au><au>Loening, Stefan A</au><au>Hawtrey, Charles E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rubin H. Flocks and Colloidal Gold Treatments for Prostate Cancer</atitle><jtitle>TheScientificWorld</jtitle><date>2011-01-01</date><risdate>2011</risdate><volume>11</volume><spage>1560</spage><epage>1567</epage><pages>1560-1567</pages><issn>1537-744X</issn><issn>2356-6140</issn><eissn>1537-744X</eissn><abstract>In the early 1950s, Rubin H. Flocks of the University of Iowa began to treat prostate cancer patients with colloidal gold (Au 198 ) therapy, evolving his technique over nearly 25 years in 1515 patients. We reviewed the long-term outcomes of Flocks' prostate cancer patients as compared to those patients treated by other methods at the University of Iowa before Flocks' chairmanship. We reviewed archived patient records, Flocks' published data, and long-term survival data from the Iowa Tumor Registry to determine short- and long-term outcomes of Flocks' work with colloidal gold. We also reviewed the literature of Flocks' time to compare his outcomes against those of his contemporaries. The use of colloidal gold, either as primary or adjunctive therapy, provided short- and long-term survival benefit for the majority of Flocks' patients as compared to historical treatment options ( p &lt; 0.001). Flocks' use of colloidal gold for the treatment of locally advanced prostate cancer offered short- and long-term survival benefits compared to other contemporary treatments.</abstract><pub>John Wiley &amp; Sons, Inc</pub><pmid>22224070</pmid><doi>10.1100/tsw.2011.145</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1537-744X
ispartof TheScientificWorld, 2011-01, Vol.11, p.1560-1567
issn 1537-744X
2356-6140
1537-744X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_d2ee6003c9294befaf40a8d19fce6297
source PubMed (Medline); Wiley Online Library Open Access
subjects Care and treatment
Colloids
Gold
Health aspects
Prostate cancer
title Rubin H. Flocks and Colloidal Gold Treatments for Prostate Cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T01%3A54%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rubin%20H.%20Flocks%20and%20Colloidal%20Gold%20Treatments%20for%20Prostate%20Cancer&rft.jtitle=TheScientificWorld&rft.au=Rosevear,%20Henry%20M&rft.date=2011-01-01&rft.volume=11&rft.spage=1560&rft.epage=1567&rft.pages=1560-1567&rft.issn=1537-744X&rft.eissn=1537-744X&rft_id=info:doi/10.1100/tsw.2011.145&rft_dat=%3Cgale_doaj_%3EA290112645%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c461t-cd553ef17029fd0060e5bc0398b1b25a95cb23e05e46c020e5401cff8d324edf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/22224070&rft_galeid=A290112645&rfr_iscdi=true